Pathology and classification of tumors of the nervous system

Neuro-Oncology of CNS Tumors

Volumn , Issue , 2006, Pages 3-72

  Reifenberger, Guido ^a   Blümcke, Ingmar ^b   Pietsch, Torsten ^c   Paulus, Werner ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649188707     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-31260-9_1     Document Type: Chapter

References (169)

1. Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Lich-ter P, Reifenberger G, Weber RG. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 2002; 34(4):416-27.
2. Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 2002; 126(5):540-4.
3. Bailey P, Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. J.B. Lippincott Co., Philadelphia, 1926.
4. Baisden BL, Brat DJ, Melhem ER, Rosenblum MK, King AP, Burger PC. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum: a lesion often misdiagnosed as glioma: report of 10 cases. Am J Surg Pathol 2001;25(4):494-9.
5. Becker AJ, Lobach M, Klein H, Normann S, Nothen MM, von Deimling A, Mizuguchi M, Elger CE, Schramm J, Wies-tler OD, Blumcke I. Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathol Appl Neurobiol 2001; 27(2):105-14.
6. Becker AJ, Klein H, Baden T, Aigner L, Normann S, Elger CE, Schramm J, Wiestler OD, Blumcke I. Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas. Acta Neuropathol (Berl) 2002; 104(4):403-8.
7. Beckner ME, Sasatomi E, Swalsky PA, Hamilton RL, Pollack IF, Finkelstein SD. Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22ql3. Hum Pathol 2004; 35(9):1105-11.
8. Betensky RA, Louis DN, Cairncross JG. Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol. 2002; 20(10):2495-9.
9. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INIl gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002; 8(ll):3461-7.
10. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002; 61(7):575-84.
11. Bostrom J, Janssen G, Messing-Junger M, Felsberg JU, Neuen-Jacob E, Engelbrecht V, Lenard HG, Bock WJ, Reifenberger G. Multiple intracranial juvenile xanthogranulomas. Case report. J Neurosurg 2000; 93(2):335-41.
12. INK4c) in atypical and anaplastic meningiomas. Am J Pathol 2001; 159(2):661-9.
13. Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocyte neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23(7):745-54.
14. Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC. Astro-blastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 2000; 10(3):342-52.
15. Brat DJ, Scheithauer BW, Eberhart CG, Burger PC. Extraven-tricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 2001; 25(10):1252-60.
16. Brat DJ, Scheithauer BW, Medina-Flores R, Rosenblum MK, Burger PC. Infiltrative astrocytomas with granular cell features (granular cell astrocytomas): a study of histopathologic features, grading, and outcome. Am J Surg Pathol 2002; 26(6):750-7.
17. Brat DJ, Scheithauer BW, Staugaitis SM, Holtzman RN, Morg-ello S, Burger PC. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol 2000; 24(3):362-8.
18. Buhren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pi-etsch T. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neu-ropathol Exp Neurol 2000; 59(3):229-40.
19. Burger PC, Pearl DK, Aldape K, Yates AJ, Scheithauer BW, Passe SM, Jenkins RB, James CD. Samll cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol 2001; 60(11):1099-104.
20. Burger PC, Scheithauer BW, Vogel SE. Surgical pathology of the nervous system and its coverings. 4th edition. Churchill Livingston, New York, Edinburg, London, Philadelphia, 2002:579-648.
21. Burnett ME, White EC, Sih S, von Haken MS, Cogen PH. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 1997; 97(1):25-31.
22. Carroll SL, Stonecypher MS. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NFl-asso-ciated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. J Neuropathol Exp Neurol 2004; 63(ll):1115-23.
23. Castellano-Sanchez AA, Ohgaki H, Yokoo H, Scheithauer BW, Burger PC, Hamilton RL, Finkelstein SD, Brat DJ. Granular cell astrocytomas show a high frequency of allelic loss but are not a genetically defined subset. Brain Pathol 2003; 13(2):185-94.
24. Cenacchi G, Giangaspero F. Emerging tumor entities and variants of CNS neoplasms. J Neuropathol Exp Neurol 2004; 63(3):185-92.
25. Cenacchi G, Giovenali P, Castrioto C, Giangaspero F. Pituicytoma: ultrastructural evidence of a possible origin from folliculo-stellate cells of the adenohypophysis. Ultrastruct Pathol 2001; 25(4):309-12.
26. Cervera-Pierot P, Varlet P, Chodkiewicz JP, Daumas-Duport C Dysembryoplastic neuroepithelial tumors located in the caudate nucleus area: report of four cases. Neurosurgery 1997; 40(5):1065-9.
27. Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: bi-allelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 2004; 63(12):1236-42.
28. Cobbers JM, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, Niederacher D, Schmidt EE, Ichimura K, Floeth F, Kir-sch L, Borchard F, Louis DN, Collins VP, Reifenberger G. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol 1998; 8(2):263-76.
29. Dahmen RP, Koch A, Denkhaus D, Tonn J.C., Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001; 61(19):7039-43.
30. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988;23(5):545-56.
31. Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C, Zazzeroni F, Gallo R, Masuelli L, Napolitano M, Maroder M, Modesti A, Giangaspero F, Screpanti I, Alesse E, Gulino A. REN(KCTDll) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. Proc Natl Acad Sci USA 2004; 101(29):10833-8.
32. Dong ZQ, Pang JC, Tong CY, Zhou LF, Ng HK. Clonality of oli-goastrocytomas. Hum Pathol 2002; 33(5):528-35.
33. Eberhart CG, Brat DJ, Cohen KJ, Burger PC. Pediatric neuroblasts brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 2000; 3(4):346-52.
34. Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002; 94(2):552-60.
35. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, Burger PC. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 2002; 12(1):36-44.
36. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000; 59(4):333-7.
37. Enam SA, Rosenblum ML, Ho KL. Neurocytoma in the cerebellum. Case report. J Neurosurg 1997; 87(1):100-2.
38. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343(19):1350-4.
39. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee-Chardin M, Chedeville G, Tam-ary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G. Muncl3-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003; 115(4):461-73.
40. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G. 01-igodendroglial tumors: refinement of candidate regions on chromosome arm lp and correlation of lp/19q status with survival. Brain Pathol 2004; 14(2):121-30.
41. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3(6):453-8.
42. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004; 64(18):6503-10.
43. Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A. Prognostic value of lp, 19q, 9p, lOq, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 2004; 63(4):314-22.
44. Fujisawa H, Marukawa K, Hasegawa M, Tohma Y, Hayashi Y, Uchiyama N, Tachibana O, Yamashita J. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J Neurosurg 2002; 97(6):1350-5.
45. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics. Tumors of Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. IARC Press, Lyon, France, 2001:171-174.
46. Gessi M, Giangaspero F, Pietsch T. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics.surprise' pathology. Brain Pathol 2003; 13(3):409-14.
47. George DH, Scheithauer BW. Central liponeurocytoma. Am J Surg Pathol 2001; 25(12):1551-5.
48. Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BR Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999; 85(9):2033-45.
49. Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002; 26(4):479-85.
50. Giangaspero F, Kaulich K, Cenacchi G, Cerasoli S, Lerch KD, Breu H, Reuter T, Reifenberger G. Lipoastrocytoma: a rare low-grade astrocytoma variant of pediatric age. Acta Neuropathol (Berl) 2002; 103(2):152-6.
51. Giangaspero F, Perilongo G, Fondelli MP, Brisigotti M, Carollo C, Burnelli R, Burger PC, Garre ML. Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 1999; 91(6):971-7.
52. Glasker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP. Reconsideration of biallelic inac-tivation of the VHL tumor suppressor gene in hemangio-blastomas of the central nervous system. J Neurol Neurosurg Psychiatry 2001; 70(5):644-8.
53. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol 2001; 60(9):863-71.
54. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Oster-mann S, Otten P, Van Melle G, de Tribolet N, Stupp R. Clinical trial substantiates the predictive value of O-6-meth-ylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004; 10(6):1871-4.
55. Herrlinger U, Felsberg J, Kuker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M. Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 2002; 52(4):390-9.
56. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, West-ermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nister M. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 1996; 56(1):164-71.
57. Hes FJ, McKee S, Taphoorn MJ, Rehal P, van Der Luijt RB, Mc-Mahon R, van Der Smagt JJ, Dow D, Zewald RA, Whittak-er J, Lips CJ, MacDonald F, Pearson PL, Maher ER. Cryptic von Hippel-Lindau disease: germline mutations in patients with hemangioblastoma only. J Med Genet 2000; 37(12):939-43.
58. Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Hepp-ner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, Weller RO, Tad-dei GL, Conti R, Del Bigio MR, Gonzalez-Campora R, Rad-hakrishnan VV, Soylemezoglu F, Uro-Coste E, Qian J, Klei-hues P, Ohgaki H. Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathol 2004; 14(3):281-9.
59. Ichimura K, Ohgaki H, Kleihues P, Collins VP. Molecular pathogenesis of astrocytic tumors. J Neuro-Oncol 2004; 70 (2):137-160.
60. Iwato M, Tachibana O, Tohma Y, Arakawa Y, Nitta H, Hasegawa M, Yamashita J, Hayashi Y Alterations of the INK4a/ARF locus in human intracranial germ cell tumors. Cancer Res 2000;60(8):2113-5.
61. Iwato M, Tachibana O, Tohma Y, Nitta H, Hayashi Y, Yamashita J. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors. Acta Neuropathol (Berl) 2000; 99(1):21-5.
62. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, et al. Ex-on scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994; 3(3):413-9.
63. Jenkinson MD, Bosma JJ, Du Plessis D, Ohgaki H, Kleihues P, Warnke P, Rainov NG. Cerebellar liponeurocytoma with an unusually aggressive clinical course: case report. Neurosurgery 2003; 53(6):1425-7.
64. Jouvet A, Fauchon F, Liberski P, Saint-Pierre G, Didier-Bazes M, Heitzmann A, Delisle MB, Biassette HA, Vincent S, Mikol J, Streichenberger N, Ahboucha S, Brisson C, Belin MF, Fe-vre-Montange M. Papillary tumor of the pineal region. Am J Surg Pathol 2003; 27(4):505-12.
65. Jouvet A, Saint-Pierre G, Fauchon F, Privat K, Bouffet E, Ru-choux MM, Chauveinc L, Fevre-Montange M. Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol 2000; 10(1):49-60.
66. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA. Immunohis-tochemical analysis of hSNF5/INIl in pediatric CNS neoplasms. Am J Surg Pathol 2004; 28(5):644-50.
67. Kam R, Chen J, Blumcke I, Normann S, Fassunke J, Elger CE, Schramm J, Wiestler OD, Becker AJ. The reelin pathway components disabled-1 and p35 in gangliogliomas - A mutation and expression analysis. Neuropathol Appl Neuro-biol 2004;30(3):225-32.
68. Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004; 203(3):814-21.
69. Kaulich K, Blaschke B, Numann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. J Neuropathol Exp Neurol 2002; 61(12):1092-9.
70. Kees UR, Spagnolo D, Hallam LA, Ford J, Ranford PR, Baker DL, Callen DF, Biegel JA. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(l;16), and enhanced MYC expression in the absence of gene amplification. Cancer Genet Cytogenet 1998; 100(2):159-64.
71. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC KIT mutations are common in testicular seminomas. Am J Pathol 2004; 164(1):305-13.
72. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastro-cytomas. Genes Chromosomes Cancer 2005; 42(1):68-77.
73. Kleihues P, Burger PC, Scheithauer BW Histological typing of tumors of the central nervous system. 2nd edition. International histological classification of tumors. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo, 1993.
74. Kleihues P, Cavenee WK. Pathology and genetics of tumors of the nervous system. World Health Organisation Classification of Tumors. IARCPress, Lyon, 2000.
75. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61(3):215-25.
76. Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, Ostertag H, von Deimling A, Mautner VF. Loss of NF1 alleles distinguish sporadic from NFl-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001; 60(9):917-20.
77. Koch A, Waha A, Tonn J.C., Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W, Reifenberger G, Wiestler OD, Pietsch T. Somatic mutations of WNT/wing-less signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001; 93(3):445-9.
78. Koch CA, Vortmeyer AO, Zhuang Z, Brouwers FM, Pacak K. New insights into the genetics of familial chromaffin cell tumors. Ann N Y Acad Sci 2002; 970:11-28.
79. Koga T, Iwasaki H, Ishiguro M, Matsuzaki A, Kikuchi M. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumors detected by comparative genomic hybridization analysis. J Pathol 2002; 197(1):98-107.
80. Komori T, Scheithauer BW, Anthony DC, Rosenblum MK, McLendon RE, Scott RM, Okazaki H, Kobayashi M. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol 1998; 22(10):1171-83.
81. Komori T, Scheithauer BW, Hirose T. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002;26(5):582-91.
82. Komotar RJ, Carson BS, Rao C, Chaffee S, Goldthwaite PT, Tihan T. Pilomyxoid astrocytoma of the spinal cord: report of three cases. Neurosurgery 2005; 56(1):191.
83. Kraus JA, Felsberg J, Tonn J.C., Reifenberger G, Pietsch T. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM 2 tumor-associated genes in su-pratentorial primitive neuroectodermal tumors and glioblastomas of childhood. Neuropathol Appl Neurobiol 2002; 28(4):325-33.
84. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A. Shared allelic losses on chromosomes lp and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54(1):91-5.
85. Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, Krex D, Klockgether T, Reifenberger G, Schlegel U. Molecular genetic alterations in glioblastomas with oligodendro-glial component. Acta Neuropathol (Berl) 2001; 101(4):311-20.
86. Kros JM, Delwel EJ, de Jong TH, Tanghe HL, van Run PR, Viss-ers K, Alers JC. Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics. Acta Neuropathol (Berl) 2002; 104(2):144-8.
87. Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol 2003; 24(4):190-6.
88. Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004; 63(4):275-86.
89. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G. The molecular and phe-notypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998; 92(3):1011-9.
90. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangio-blastomas. Cancer Res 1998; 58(3):504-8.
91. Lemeta S, Pylkkanen L, Sainio M, Niemela M, Saarikoski S, Husgafvel-Pursiainen K, Bohling T. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas. J Neuropathol Exp Neurol 2004; 63 (10): 1072-9.
92. Levy A, Lightman S. Molecular defects in the pathogenesis of pituitary tumors. Front Neuroendocrinol 2003; 24(2):94-127.
93. Louis DN, von Deimling A, Dickersin GR, Dooling EC, Seiz-inger BR. Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastruc-tural, and molecular genetic study. Hum Pathol 1992; 23(12):1402-9.
94. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004; 101(1):146-55.
95. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997; 56(10):1098-104.
96. Martin AJ, Summersgill BM, Fisher C, Shipley JM, Dean AF. Chromosomal imbalances in meningeal solitary fibrous tumors. Cancer Genet Cytogenet 2002; 135(2):160-4.
97. Masuoka J, Brandner S, Paulus W, Soffer D, Vital A, Chimelli L, Jouvet A, Yonekawa Y, Kleihues P, Ohgaki H. Germline SD-HD mutation in paraganglioma of the spinal cord. Oncogene 2001; 20(36):5084-6.
98. Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vor-werk C, Von Deimling A, Van Landeghem F, Meyermann R, Bornemann A, Muller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K. Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl) 2003; 105(6):529-36.
99. Mechtersheimer G, Otano-Joos M, Ohl S, Benner A, Lehnert T, Willeke F, Moller P, Otto HF, Lichter P, Joos S. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 25(4):362-9.
100. Melean G, Sestini R, Ammannati F, Papi L. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet 2004; 129(1):74-84.
101. Miettinen MM, el-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S. Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas. Mod Pathol 1997; 10(12):1194-200.
102. Miyakawa A, Ichimura K, Schmidt EE, Varmeh-Ziaie S, Collins VP. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumors. Br J Cancer 2000; 82(3):543-9.
103. Mollemann M, Wolter M, Felsberg J, Collins VP, Reifenberger G. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer 2005; 113(3):379-85.
104. Montesinos-Rongen M, Kuppers R, Schluter D, Spieker T, Van Roost D, Schaller C, Reifenberger G, Wiestler OD, Deck-ert-Schluter M. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 1999; 155(6):2077-86.
105. Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004; 103(5):1869-75.
106. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J.C., Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 2002; 161(1):313-9.
107. Murakami I, Gogusev J, Fournet JC, Glorion C, Jaubert F. Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone. Hum Pathol 2002; 33(5):555-60.
108. Nakamura M, Kishi M, Sakaki T, Hashimoto H, Nakase H, Shi-mada K, Ishida E, Konishi N. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res 2003; 63(4):737-41.
109. ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol 2001; 11 (2): 159-68.
110. Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC 3rd, Hawkins CE, Weiss SK. Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology. 2004; 62(12):2270-6.
111. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003; 63(7):1602-7.
112. Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP. Mutation of the von Hippel-Lindau tumor suppressor gene in capillary hemangioblastomas of the central nervous system. J Pathol 1996; 179(2):151-6.
113. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Pa-tre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64(19):6892-9.
114. Okada Y, Nishikawa R, Matsutani M, Louis DN. Hypomethyl-ated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exp Neurol 2002; 61(6):531-8.
115. Ono Y, Ueki K, Joseph JT, Louis DN. Homozygous deletions of the CDKN2/pl6 gene in dural hemangiopericytomas. Acta Neuropathol (Berl) 1996; 91(3):221-5.
116. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4(6):448-56.
117. Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, Garcia-Lopez JL, Piquer J, Safont MJ, Bal-ana C, Sanchez-Cespedes M, Garcia-Villanueva M, Arrib-as L, Esteller M. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to te-mozolomide in primary gliomas. Clin Cancer Res 2004; 10(15):4933-8.
118. Perry A, Aldape KD, George DH, Burger PC. Small cell astrocytoma: an aggressive variant that is clinicopathological-ly and genetically distinct from anaplastic oligodendroglioma. Cancer 2004; 101(10):2318-26.
119. Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 2002; 12(2):183-90.
120. Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas. J Neuro-Oncol 2004; 70(2): 183-202.
121. Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 2002; 61(11):947-55.
122. Petersen I, Hidalgo A, Petersen S, Schluns K, Schewe C, Pacyna-Gengelbach M, Goeze A, Krebber B, Knosel T, Kaufmann O, Szymas J, von Deimling A. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 2000; 10(3):395-401.
123. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J.C., So-rensen N, Berthold F, Henk B, Schmandt N, Wolf HK, von Deimling A, Wainwright B, Chenevix-Trench G, Wiestler OD, Wicking C. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Dro-sophilapatched.Cancer Res 1997; 57(ll):2085-8.
124. Pietsch T, Taylor MD, Rutka JT. Molecular pathogenesis of childhood brain tumors. J Neurooncol 2004; 70(2):203-15.
125. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR. Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 2002; 415(6870):436-42.
126. Puduvalli VK. Brain metastases: biology and the role of the brain microenvironment. Curr Oncol Rep 2001; 3(6):467-75.
127. Rajaram V, Brat DJ, Perry A. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. Hum Pathol 2004; 35(11):1413-8.
128. Reifenberger G, Collins VP. Pathology and molecular genetics of astrocytic gliomas. J Mol Med 2004; 82(10):656-70.
129. Reifenberger G, Kaulich K, Wiestler OD, Blumcke I. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas. Acta Neuropathol (Berl) 2003; 105(4):358-64.
130. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology J Neuropathol Exp Neurol 2003; 62(2):111-26.
131. Reifenberger G, Weber T, Weber RG, Wolter M, Brandis A, Kuchelmeister K, Pilz P, Reusche E, Lichter P, Wiestler OD. Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol 1999; 9(4):617-26.
132. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998; 58(9):1798-803
133. Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Oh-gaki H. Genetic profile of gliosarcomas. Am J Pathol 2000; 156(2):425-32.
134. Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 2004;3(5):430-46.
135. Rickert CH, Dockhorn-Dworniczak B, Simon R, Paulus W Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 1999; 155(5):1445-51.
136. Rickert CH, Simon R, Bergmann M, Dockhorn-Dworniczak B, Paulus W. Comparative genomic hybridization in pineal parenchymal tumors. Genes Chromosomes Cancer 2001; 30(1):99-104.
137. Rickert CH, Paulus W No chromosomal imbalances detected by comparative genomic hybridisation in subependymal giant cell astrocytomas. Acta Neuropathol (Berl) 2002; 104(2):206-8.
138. Rickert CH, Paulus W Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence. J Neuropathol Exp Neurol 2004; 63(5):399-417.
139. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Mari-neau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363(6429):515-21.
140. ARF are frequently and differentially methylated in ependymal tumors. Neuropathol Appl Neurobiol 2003; 29(6):574-83.
141. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Moha-patra G, Collins VP, Feuerstein BG. Comparative genomic hybridization in patients with supratentorial and infraten-torial primitive neuroectodermal tumors. Cancer 1999; 86(2):331-9.
142. Sakuma Y, Sakurai S, Oguni S, Satoh M, Hironaka M, Saito K. c-kit gene mutations in intracranial germinomas. Cancer Sci 2004;95(9):716-20.
143. Sanoudou D, Tingby O, Ferguson-Smith MA, Collins VP, Coleman N. Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 2000; 82(6):1218-22.
144. Scheithauer BW, Woodruff JM, Erlandson RA. Tumors of the peripheral nervous system. Atlas of Tumor Pathology. Third series. Fascicle 24. Armed Forces Institute of Pathology, Washington, D.C., 1997.
145. Schramm J, Luyken C, Urbach H, Fimmers R, Blumcke I. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery 2004; 55(2):340-7.
146. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lazaro C. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000; 9(20):3055-64.
147. Shih AH, Holland EC. Developmental neurobiology and the origin of brain tumors. J Neuro-Oncol 2004; 70(2): 125-135.
148. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Itur-ria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001; 93(16):1246-56.
149. Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997; 56(5):551-6.
150. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286(5446): 1957-9.
151. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Ag-atep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, DuraWT, Wainwright B, Squire JA, Rutka JT, Hogg D. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002; 31(3):306-10.
152. Teo JG, Gultekin SH, Bilsky M, Gutin P, Rosenblum MK. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including 'rosetted') islands: report of 4 cases. Am J Surg Pathol 1999; 23(5):502-10.
153. Thiessen B, Finlay J, Kulkarni R, Rosenblum MK. Astroblasto-ma: does histology predict biologic behavior? J Neuroon-col 1998;40(1):59-65.
154. Tihan T, Fisher PG, Kepner JL, Godfraind C, McComb RD, Goldthwaite PT, Burger PC. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999; 58(10):1061-8.
155. Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system. A clin-icopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med 2003; 127(4):432-9.
156. Tong CY, Ng HK, Pang JC, Hu J, Hui AB, Poon WS. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas. Histopathology 2000; 37(2):160-5.
157. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 72(5):791-800.
158. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Mer-el P, Delattre O, Thomas G, Rouleau GA. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994;3(1):147-51.
159. Virchow R. Die krankhaften Geschwulste. Achtzehnte Vor-lesung: Psammome, Melanome, Gliome. Verlag von August Hirschwald, Berlin, 1864/65:106-169.
160. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albre-cht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG, et al. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. Cancer Res 1994; 54(6):1397-401.
161. Waha A, Waha A, Koch A, Meyer-Puttlitz B, Weggen S, Sorensen N, Tonn J.C., Albrecht S, Goodyer CG, Berthold F, Wiestler OD, Pietsch T. Epigenetic silencing of the HIC-1 gene in human medulloblastomas. J Neuropathol Exp Neurol 2003; 62(11):1192-201.
162. Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Var-ley JM, Evans DG. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 2003; 40(11):802-6.
163. Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 4th edition. Mosby, St. Louis, 2001.
164. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regula-tion of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic he-mangioblastomas. Cancer Res 1995; 55(6):1358-64.
165. INK4b) tumor suppressor genes. J Neuropathol Exp Neurol 2001; 60(12):1170-80.
166. Wrocklage C, Gold H, Hackl W, Buchfelder M, Fahlbusch R, Paulus W Increased menin expression in sporadic pituitary adenomas. Clin Endocrinol (Oxf) 2002; 56(5):589-94.
167. Zhou XP, Marsh DJ, Morrison CD, Chaudhury AR, Maxwell M, Reifenberger G, Eng C. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 2003; 73(5):1191-8.
168. Zulch KJ. Histological typing of tumors of the central nervous system. International histological classification of tumors, no.21, World Health Organization, Geneva, 1979.
169. Zurawel RH, Chiappa SA, Allen C, Raffel C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 1998; 58(5):896-9.